Article: New antibiotic - Cubicin - shipped to U.S. institutions.

Article: Phase 3 Data on CUBICIN Published in Journal Clinical ...
Business Wire;  June 16, 2004 ;     700+ words ... ... treatment relapse rates; -- CUBICIN demonstrated comparable efficacy ... Staphylococcus aureus (MSSA). -- CUBICIN demonstrated comparable efficacy ... resistant Staphylococcus aureus (MRSA). -- CUBICIN was safe and well tolerated ...

Article: SMC OKs Cubicin for MRSA indications.
Pharma Marketletter;  March 17, 2008 ;     432 words ... ... Medicines Consortium, the agency that governs National Heath Service drug use in Scotland, has recommended its antibiotic Cubicin (daptomycin) for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia associated with heart infections ...

Article: Novartis' MRSA drug Cubicin launched in UK.
Pharma Marketletter;  September 24, 2007 ;     570 words ...Swiss drug major Novartis has launched its new antibiotic Cubicin (daptomycin) in the UK for the treatment of both methicillin ... important and welcomed development in the battle against serious MRSA infection." Last month, the Committee for Medical Products ...

Article: FDA Approves Expanded Label for IV Antibiotic CUBICIN(R) ...
Business Wire;  May 25, 2006 ;     700+ words ... ... S. aureus) and MRSA (methicillin-resistant ... alone each year. CUBICIN will be the only ... America has identified MRSA as one of six top ... The FDA approval of CUBICIN today for the treatment ... infections caused by MRSA.) For full prescribing ... information, visit www.cubicin.com. ...

Article: New Licence for Cubicin(R) (daptomycin), the First in a ...
PR Newswire;  September 12, 2007 ;     700+ words ... ... resistant Staphylococcus aureus (MSSA and MRSA) bloodstream infections (bacteraemia ... new option for healthcare professionals. MRSA is a frequent cause of bacteraemia and ... There is evidence that some strains of MRSA are developing resistance to existing antibiotic ...

Article: Cubist Pharmaceuticals Reports Positive Outcome from FDA ...
Business Wire;  March 7, 2006 ;     700+ words ... ... resistant S. aureus, or MRSA. CUBICIN, if approved for an ... called lipopeptides. CUBICIN is currently the only ... Staphylococcus aureus (MSSA and MRSA) in complicated skin ... indication statement for CUBICIN. The FDA has granted ...

Article: CUBICIN Approved for S. aureus Bloodstream Infections in ...
Business Wire;  August 1, 2007 ;     700+ words ... ... methicillin-resistant S. aureus (MRSA)." About CUBICIN CUBICIN is currently the only ... susceptible strains only). CUBICIN is also approved in the U ... sided endocarditis, caused by MRSA and MSSA. CUBICIN is not indicated for the treatment ...